SPTLC1
Serine palmitoyltransferase 1
Also known as: hLCB1, HSAN1, HSN1, LCB1, SPTC1_HUMAN, SPTI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15269
- Gene
- SPTLC1
- Ensembl
- ENSG00000090054
- Chromosome
- 9
- Canonical length
- 473 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
This gene encodes a member of the class-II pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is the long chain base subunit 1 of serine palmitoyltransferase. Serine palmitoyltransferase converts L-serine and palmitoyl-CoA to 3-oxosphinganine with pyridoxal 5'-phosphate and is the key enzyme in sphingolipid biosynthesis. Mutations in this gene were identified in patients with hereditary sensory neuropathy type 1. Alternatively spliced variants encoding different isoforms have been identified. Pseudogenes of this gene have been defined on chromosomes 1, 6, 10, and 13. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
473 residues, UniProt reviewed canonical sequence.
>O15269|SPTLC1
1 MATATEQWVL VEMVQALYEA PAYHLILEGI LILWIIRLLF SKTYKLQERS DLTVKEKEEL
61 IEEWQPEPLV PPVPKDHPAL NYNIVSGPPS HKTVVNGKEC INFASFNFLG LLDNPRVKAA
121 ALASLKKYGV GTCGPRGFYG TFDVHLDLED RLAKFMKTEE AIIYSYGFAT IASAIPAYSK
181 RGDIVFVDRA ACFAIQKGLQ ASRSDIKLFK HNDMADLERL LKEQEIEDQK NPRKARVTRR
241 FIVVEGLYMN TGTICPLPEL VKLKYKYKAR IFLEESLSFG VLGEHGRGVT EHYGINIDDI
301 DLISANMENA LASIGGFCCG RSFVIDHQRL SGQGYCFSAS LPPLLAAAAI EALNIMEENP
361 GIFAVLKEKC GQIHKALQGI SGLKVVGESL SPAFHLQLEE STGSREQDVR LLQEIVDQCM
421 NRSIALTQAR YLEKEEKCLP PPSIRVVVTV EQTEEELERA ASTIKEVAQA VLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPTLC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 52 nTPM
- esophagus: 51 nTPM
- parathyroid gland: 47 nTPM
- epididymis: 46 nTPM
- breast: 43 nTPM
- kidney: 42 nTPM
Single-cell type
- esophageal apical cells: 738 nCPM
- early spermatids: 186 nCPM
- syncytiotrophoblasts: 175 nCPM
- neutrophils: 160 nCPM
- neutrophil progenitors: 148 nCPM
- extravillous trophoblasts: 108 nCPM
Immune cell
- non-classical monocyte: 38 nTPM
- intermediate monocyte: 36 nTPM
- basophil: 33 nTPM
- neutrophil: 33 nTPM
- classical monocyte: 31 nTPM
- myeloid DC: 28 nTPM
Brain region
- white matter: 43 nTPM
- medulla oblongata: 38 nTPM
- spinal cord: 37 nTPM
- choroid plexus: 35 nTPM
- basal ganglia: 35 nTPM
- midbrain: 35 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPTLC1.
Disease | AllUniProt
Conditions SPTLC1 is implicated in, by any mechanism.
- Amyotrophic lateral sclerosis 27, juvenile (ALS27) MIM:620285
- Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) MIM:162400
Disease | GeneticClinVar
14 pathogenic / likely-pathogenic of 554 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary sensory and autonomic neuropathy type 1
- Neuropathy, hereditary sensory and autonomic, type 1A
- Amyotrophic lateral sclerosis 27, juvenile
- Charcot-Marie-Tooth disease
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.13
- DepMap mean gene effect
- -0.66
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide biosynthetic process
- positive regulation of lipophagy
- sphinganine biosynthetic process
- sphingolipid biosynthetic process
- sphingolipid metabolic process
- sphingomyelin biosynthetic process
- sphingosine biosynthetic process
- regulation of fat cell apoptotic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPTLC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPTLC1 as an antibody target. Whether an autoantibody or antibody against SPTLC1 could matter depends on whether native SPTLC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPTLC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPTLC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...